CorMedix (CRMD)

• Market cap: $618M
• 1 day: 5.39%
• 5 days: 2.49%
• 1 month: 16.54%
• 3 months: 0.9%
• 6 months: -29.23%
• Year to date: -35.69%
• 1 year: -13.69%
• 5 years: -6.79%
• 10 years: -64.45%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 191